NEW YORK, April 10, 2024 – Behrman Capital (“Behrman”), a private equity investment firm based in New York, today announced that it has acquired Vista Apex (the “Company”), a leading manufacturer of consumable dental products for preventative oral hygiene, endodontics,…
NEW YORK, February 26, 2024 – kSARIA Corporation (“kSARIA” or the “Company”), a leading producer and supplier of mission-critical connectivity solutions for the aerospace and defense end markets and a portfolio company of Behrman Capital, today announced that it has…
Acquisition Expands Micross’ High-Reliability Power Management Solution Capabilities Melville, NY – January 10, 2023 – Micross Components, Inc. (“Micross” or the “Company”), a leading provider of high-reliability microelectronic product and service solutions for aerospace, defense, space, medical and industrial applications…
NEW YORK, January 4, 2023 – George Holding, Inc. (“George Industries” or the “Company”), a leading designer and manufacturer of mission-critical and highly engineered components for the defense, aerospace and industrial sectors and a portfolio company of Behrman Capital, today announced a…
NEW YORK, August 17, 2022 – Behrman Capital (“Behrman”), a private equity investment firm based in New York, today announced that it has acquired George Holding, Inc. (“George Industries” or the “Company”), a leading designer and manufacturer of mission-critical and…
NEW YORK, June 21, 2022 – Behrman Capital, a private equity investment firm based in New York, today announced the sale of its portfolio company Emmes (the “Company”) to affiliates of New Mountain Capital. The transaction is expected to close…
Acquisition Further Expands and Differentiates Micross’ High-Reliability Product Manufacturing Capabilities Melville, NY – May 3, 2022 – Micross Components, Inc. (“Micross” or the “Company”), a leading provider of high-reliability microelectronic product and service solutions for aerospace, defense, space, medical and…
Casimir Further Differentiates Emmes’ Industry-Leading Rare Disease Research Capabilities Rockville, MD, March 10, 2022 – Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company…
Continuation Fund Provides Incremental Capital to Accelerate Growth and Support Future M&A New York, NY, February 28, 2022 – Behrman Capital, a private equity investment firm based in New York, today announced the closing of Behrman Capital Micross CF L.P.,…
Third Add-on Acquisition Under Behrman’s Ownership Expands European Presence in Germany; Adds New Electronic Data Capture Tool to Enhance Real World Evidence Research Rockville, MD, December 21, 2021 – Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated…